Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Dissolution Testing in Pharma - From Development to Regulatory Approval" training has been added to ResearchAndMarkets.com's offering. Dissolution ...
TRADE NEWS: Agilent Technologies Introduces Dissolution Apparatus for Pharmaceutical Quality Control
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE:A) today introduced the 708-DS Dissolution Apparatus, a quality control instrument that can be configured for manual and ...
Numerous therapeutic advantages are offered by sustained-release drugs, which release active pharmaceutical ingredients (APIs) in a gradual manner. However, the QC of such drugs through conventional ...
System addresses the pharmaceutical industry’s need for compliant, semi-automated testing of nanoparticle drug formulations. SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results